Prior reports suggest that osteoarticular infections may be increasing over time.
We sought to determine if incidence rates, median in-hospital costs, and length of stay (LOS) of osteomyelitis, septic arthritis (SA), and combined infections have changed over time for pediatric patients, and how they compare to previously reported rates.
The Kids’ Inpatient Database (KID), a US national sample of pediatric hospital discharge records from 1997, 2000, 2003, 2006, 2009, and 2012, was used to determine yearly estimated counts of infections in children 20 years of age or younger. US census data was used to calculate yearly incidence rates. Trend tests using linear contrast analysis were used to compare estimated median LOS and inflation-adjusted median costs over time for each type of infection.
From 1997 through 2012, the incidence rate of osteomyelitis increased from 7.9 to 10.5 per 100,000, SA was unchanged from 5.3 to 5.2 per 100, and combined infections increased from 0.8 to 1.3 per 100,000. Median LOS from 1997 to 2012 showed no significant change for osteomyelitis (5.0 to 4.9 days), SA (4.4 to 4.1 days), or combined infections (6.5 to 6.8 days). Median in-hospital costs from 1997 to 2012 increased for osteomyelitis ($7735 to $11,823), SA ($5041 to $10,574), and combined infections ($12,691 to $16,260).
In pediatric patients, the estimated incidence rate of SA appeared stable, while rates of osteomyelitis and combined infections increased. These estimated rates fall within previously reported ranges. Despite stable LOS, costs have increased over time.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
2013 Health Care Cost and Utilization Report. Washington DC; 2014. Available from https://www.healthcostinstitute.org/images/pdfs/2013-HCCUR-12-17-14.pdf.
Arnold SR, Elias D, Buckingham SC, et al. Changing patterns of acute hematogenous osteomyelitis and septic arthritis: emergence of community-associated methicillin-resistant Staphylococcus aureus. J Pediatr Orthop. 2006;26(6):703–708.
Arnold JC, Cannavino CR, Ross MK, et al. Acute bacterial osteoarticular infections: eight-year analysis of C-reactive protein for oral step-down therapy. Pediatrics. 2012;130(4):e821–8.
Benvenuti M, An T, Amaro E, et al. Double-edged sword: musculoskeletal infection provoked acute phase response in children. Orthop Clin N Am. 2017;48(2):181–197.
Chou ACC, Mahadev A. The use of C-reactive protein as a guide for transitioning to oral antibiotics in pediatric osteoarticular infections. J Pediatr Orthop. 2016;36(2):173–177.
Cohen E, Lifshitz K, Fruchtman Y, Eidelman M, Leibovitz E. Current data on acute haematogenous osteomyelitis in children in Southern Israel: epidemiology, microbiology, clinics and therapeutic consequences. Int Orthop. 2016;40(9):1987–1994.
Crawford M, Church J, Akin B. CPI Detailed Report – United States Bureau of Labor Statistics; 2015. Available from http://data.bls.gov/pdq/SurveyOutputServlet.
Dagan R. Management of acute hematogenous osteomyelitis and septic arthritis in the pediatric patient. Pediatr Infect Dis J. 1993;12(1):88–92.
Dartnell J, Ramachandran M, Katchburian M. Haematogenous acute and subacute paediatric osteomyelitis: a systematic review of the literature. J Bone Joint Surg Br. 2012;94(5):584–595.
de Kraker MEA, Wolkewitz M, Davey PG, et al. Clinical impact of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay related to methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrob Agents Chemother. 2011;55(4):1598–1605.
Dodwell ER. Osteomyelitis and septic arthritis in children: current concepts. Curr Opin Pediatr. 2013;25(1).
Freedman J, Guller U, Benjamin DK, et al. National trends in health care utilization and racial and socioeconomic disparities in pediatric pyogenic arthritis. J Pediatr Orthop. 2006;26(6):709–715.
Gafur OA, Copley LAB, Hollmig ST, Browne RH, Thornton LA, Crawford SE. The impact of the current epidemiology of pediatric musculoskeletal infection on evaluation and treatment guidelines. J Pediatr Orthop. 2008;28(7):777–785.
Geirsson AJ, Statkevicius S, Vikingsson A. Septic arthritis in Iceland 1990–2002: increasing incidence due to iatrogenic infections. Ann Rheum Dis. 2008;67(5):638–643.
Gillespie WJ. The epidemiology of acute haematogenous osteomyelitis of childhood. Int J Epidemiol. 1985;14(4):600–606.
Gillespie WJ. Epidemiology in bone and joint infection. Infect Dis Clin N Am. 1990;4(3):361–376.
Goergens ED, McEvoy A, Watson M, Barrett IR. Acute osteomyelitis and septic arthritis in children. J Paediatr Child Health. 41(1–2):59–62.
Hawkshead JJ, Patel NB, Steele RW, Heinrich SD. Comparative severity of pediatric osteomyelitis attributable to methicillin-resistant versus methicillin-sensitive Staphylococcus aureus. J Pediatr Orthop. 29(1):85–90.
Ilharreborde B. Sequelae of pediatric osteoarticular infection. Orthop Traumatol Surg Res. 2015;101(1):S129–S137.
Jagodzinski NA, Kanwar R, Graham K, Bache CE. Prospective evaluation of a shortened regimen of treatment for acute osteomyelitis and septic arthritis in children. J Pediatr Orthop. 2009;29(5):518–525.
Lee GE, Lorch SA, Sheffler-Collins S, Kronman MP, Shah SS. National hospitalization trends for pediatric pneumonia and associated complications. Pediatrics. 2010;126(2):204–213.
Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis. 2011;52(3):285–292.
Malcius D, Trumpulyte G, Barauskas V, Kilda A. Two decades of acute hematogenous osteomyelitis in children: are there any changes?. Pediatr Surg Int. 2005;21(5):356–359.
Monsalve J, Kan JH, Schallert EK, Bisset GS, Zhang W, Rosenfeld SB. Septic arthritis in children: frequency of coexisting unsuspected osteomyelitis and implications on imaging work-up and management. Am J Roentgenol. 2015;204(6):1289–1295.
Murillo O, Grau I, Lora-Tamayo J, et al. The changing epidemiology of bacteraemic osteoarticular infections in the early 21st century. Clin Microbiol Infect. 2015;21(3):254.e1–8.
Nathwani D. Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter? J Antimicrob Chemother. 2003;51 Suppl 2:ii37–44.
Nelson JD. The bacterial etiology and antibiotic management of septic arthritis in infants and children. Pediatrics. 1972;50(3):437–440.
Okubo Y, Nochioka K, Marcia T. Nationwide survey of pediatric septic arthritis in the United States. J Orthop. 2017;14(3):342–346.
Paakkonen M, Peltola H. Treatment of acute septic arthritis. Pediatr Infect Dis J. 2013;32(6):684–685.
Peltola H, Pääkkönen M, Kallio P, Kallio MJT, Osteomyelitis-Septic Arthritis (OM-SA) Study Group. Prospective, randomized trial of 10 days versus 30 days of antimicrobial treatment, including a short-term course of parenteral therapy, for childhood septic arthritis. Clin Infect Dis. 2009;48(9):1201–1210.
Peltola H, Pääkkönen M, Kallio P, Kallio MJT, Osteomyelitis-Septic Arthritis Study Group. Short- versus long-term antimicrobial treatment for acute hematogenous osteomyelitis of childhood. Pediatr Infect Dis J. 2010;29(12):1123–1128.
Pendleton A, Kocher MS. Methicillin-resistant Staphylococcus aureus bone and joint infections in children. J Am Acad Orthop Surg. 2015;23(1):29–37.
Riise OR, Kirkhus E, Handeland KS, et al. Childhood osteomyelitis-incidence and differentiation from other acute onset musculoskeletal features in a population-based study. BMC Pediatr. 2008;8:45.
Rossaak M, Pitto RP. Osteomyelitis in Polynesian children. Int Orthop. 2005;29(1):55–58.
Sarkissian EJ, Gans I, Gunderson MA, Myers SH, Spiegel DA, Flynn JM. Community-acquired methicillin-resistant Staphylococcus aureus musculoskeletal infections: emerging trends over the past decade. J Pediatr Orthop. 36(3):323–327.
Schaub RL, Rodkey ML. Deep vein thrombosis and septic pulmonary emboli with MRSA osteomyelitis in a pediatric patient. Pediatr Emerg Care. 2012;28(9):911–912.
Simon TD, Berry J, Feudtner C, et al. Children with complex chronic conditions in inpatient hospital settings in the United States. Pediatrics. 2010;126(4):647–655.
Stockmann C, Ampofo K, Pavia AT, et al. National trends in the incidence, outcomes and charges of pediatric osteoarticular infections, 1997–2012. Pediatr Infect Dis J. 2015;34(6):672–674.
U.S. Department of Health and Human Services; Centers for Disease Control and Prevention; National Center for Health Statistics. Bridged-Race Population Estimates, United States July 1st Resident Population by State, County, Age, Sex, Bridged-Race, and Hispanic Origin. Compiled from 1990–1999 Bridged-Race Intercensal Population Estimates; 2004. Available from http://wonder.cdc.gov/bridged-race-v2014.html.
U.S. Department of Health and Human Services; Centers for Disease Control and Prevention; National Center for Health Statistics. Bridged-Race Population Estimates, United States July 1st Resident Population by State, County, Age, Sex, Bridged-Race, and Hispanic Origin. Revised Bridged-Race 2000–2009 Intercensal Population Estimates; 2012. Available from http://wonder.cdc.gov/bridged-race-v2014.html.
U.S. Department of Health and Human Services; Centers for Disease Control and Prevention; National Center for Health Statistics. Intercensal Estimates of the Resident Population of the United States for July 1, 2000–July 1, 2009, by Year, County, Single-Year of Age (0, 1, 2, .., 85 Years and over), Bridged Race, Hispanic Origin, and Sex; 2012. Available from http://www.cdc.gov/nchs/nvss/bridged_race.htm.
U.S. Department of Health and Human Services; Centers for Disease Control and Prevention; National Center for Health Statistics. Bridged-Race Population Estimates, United States July 1st Resident Population by State, County, Age, Sex, Bridged-Race, and Hispanic Origin. Bridged-Race Vintage 2014 (2010–2014) Postcensal Population Estimates; 2015. Available from https://wonder.cdc.gov/bridged-race-v2017.html.
Vander Have KL, Karmazyn B, Verma M, et al. Community-associated methicillin-resistant Staphylococcus aureus in acute musculoskeletal infection in children: a game changer. J Pediatr Orthop. 2009;29(8):927–931.
Welkon CJ, Long SS, Fisher MC, Alburger PD. Pyogenic arthritis in infants and children: a review of 95 cases. Pediatr Infect Dis. 1986;5(6):669–676.
Conflict of Interest
Gabriella Safdieh, MD, Jason Silberman, BA, Joseph Nguyen, MPH, Shevaun Doyle, MD, John Blanco, MD, David Scher, MD, Daniel Green, MD, MS, Roger Widmann, MD, and Emily Dodwell, MD, MPH, FRCSC, declare that they have no conflict of interest. Joseph Nguyen, MPH, reports grants from Clinical Translational Science Center (CTSC), National Center for Advancing Translational Sciences (NCATS), outside the submitted work.
Required Author Forms
Disclosure forms provided by the authors are available with the online version of this article.
Level of Evidence: Level II, retrospective national database study
About this article
Cite this article
Safdieh, G., Silberman, J., Nguyen, J. et al. Pediatric Septic Arthritis and Osteomyelitis in the USA: A National KID Database Analysis. HSS Jrnl 15, 159–166 (2019). https://doi.org/10.1007/s11420-018-9644-2
- septic arthritis
- osteoarticular infections
- KID database